Related Experiment Video
Updated: Sep 2, 2025

09:17
Optimizing Extracellular Vesicle Delivery Using a Core-Sheath 3D-Bioprinted Scaffold for Chronic Wound Management
Published on: February 28, 2025
417
Tailored Extracellular Vesicles: Novel Tool for Tissue Regeneration
Linli Li1,2, Peipei Wu1,2, Hui Qian1,2
1Aoyang Institute of Cancer, Affiliated Aoyang Hospital of Jiangsu University, 279 Jingang Road, Suzhou, 215600 Jiangsu, China.
Stem Cells International
|August 2, 2022
Summary
Engineered extracellular vesicles (EVs) show promise for tissue repair by overcoming limitations like low efficacy and poor targeting. Modifications enhance their regenerative potential for clinical applications.
Area of Science:
- Biomedical Engineering
- Regenerative Medicine
- Cell Biology
Background:
- Extracellular vesicles (EVs) are crucial for intercellular communication in tissue injury and regeneration.
- Current EV applications face challenges including insufficient therapeutic efficacy, poor targeting, low yield, and rapid clearance.
- EVs possess inherent properties like small size, low immunogenicity, and the ability to carry bioactive molecules.
Purpose of the Study:
- To summarize recent advancements in EV modification strategies for enhanced tissue repair.
- To discuss the opportunities and challenges associated with the clinical translation of engineered EVs.
- To highlight how EV engineering can improve therapeutic efficacy and targeting for regenerative medicine.
Main Methods:
- Engineering EVs to encapsulate therapeutic cargos (proteins, nucleic acids, drugs).
- Modifying EVs with targeting moieties (peptides, antibodies, aptamers, nanoparticles).
- Utilizing extracellular vesicle mimetics (EMs) and self-assembly nanocomplexes for improved production and purification.
- Combining EVs with biomaterials (hydrogels, scaffolds) for sustained release and synergistic effects.
Main Results:
- Engineered EVs demonstrate improved therapeutic efficacy and targeting capabilities.
- EV modifications address limitations such as low yield and rapid clearance.
- Combination therapies with biomaterials enhance long-term regenerative outcomes.
- EV mimetics offer simplified production and purification processes.
Conclusions:
- EV modification strategies offer significant potential for improving regenerative outcomes in tissue repair.
- Engineered EVs present a promising platform for addressing challenges in clinical translation.
- Further research is needed to optimize EV engineering for widespread clinical application.
Related Concept Videos
Clinical Applications of Epidermal Stem Cells
2.7K
Epidermal stem cells (EpiSCs) are mainly located at the basal layer of the epidermis. These cells repair minor injuries of the skin and replace dead skin cells. However, EpiSCs’ cannot heal severe wounds such as major burns or those from diabetes or hereditary disorders. In such cases, culturing the epidermal stem cells from the patient is possible and has yielded successful treatment options, such as laboratory-grown skin grafts. These grafts are synthesized using a patient’s own...
2.7K
Stem Cell Therapy for Tissue Regeneration
4.2K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.2K
Overview of Exosomes
2.8K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.8K

